Sicit Group held an inauguration ceremony 10 November at its new production facility in León, Mexico.

The 55,000 sq m facility will produce the company’s amino acid and moringa plant-extract products.

Based in the central Mexican state of Guanajuato, the plant represents the Italian company’s first international capacity expansion for its peptide manufacturing process using waste material from the leather industry.

Sicit Group has invested around Euro 40 million in the project. This investment was raised using its own resources, CEO Sergi Barrull told New AG International on the side lines at the event.

Construction of the facility began in 2023, and is now ramping up for commercial production. The factory is located in León because it is the centre of the Mexican leather industry, based on automobile and shoe manufacturing.

Formerly general manager at Sicit Group, Sergi Barrull was appointed CEO in October.

Franz Prieschl, Chief Commercial Officer, told New AG International that Sicit would continue with its b2b model, producing amino acids for other labels. “The is the success model for the last 60 years. We’ll keep on doing what we do best – the production of high quality raw materials.”